Cargando…

Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis

INTRODUCTION: AFFIRM-AHF and IRONMAN demonstrated lower rates of the combined endpoint recurrent heart failure (HF) hospitalizations and cardiovascular death (CVD) using intravenous (IV) ferric carboxymaltose (FCM) and ferric derisomaltose (FDI), respectively in patients with HF and iron deficiency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vukadinović, Davor, Abdin, Amr, Emrich, Insa, Schulze, P. Christian, von Haehling, Stephan, Böhm, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116902/ https://www.ncbi.nlm.nih.gov/pubmed/37074386 http://dx.doi.org/10.1007/s00392-023-02207-2

Ejemplares similares

Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
por: Abdin, Amr, et al.
Publicado: (2022)

Iron Deficiency in Heart Failure: A Practical Guide
por: Ebner, Nicole, et al.
Publicado: (2013)

Iron deficiency in heart failure
por: Loncar, Goran, et al.
Publicado: (2021)

Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?
por: Ebner, Nicole, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in Germany: a nationwide retrospective analysis
por: Kerwagen, Fabian, et al.
Publicado: (2023)

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial‐IRON Trial
por: Núñez, Julio, et al.
Publicado: (2020)

Intravenous Iron Repletion Does Not Significantly Decrease Platelet Counts in CKD Patients with Iron Deficiency Anemia
por: Dossabhoy, Neville R., et al.
Publicado: (2013)

When is high-dose intravenous iron repletion needed? Assessing new treatment options
por: Gozzard, David
Publicado: (2011)

Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial
por: Rosano, Giuseppe, et al.
Publicado: (2023)

IRONMAN adds support for iron repletion in HF
por: Fernández-Ruiz, Irene
Publicado: (2022)

Lack of efficacy of ergocalciferol repletion
por: Kebede, Amal, et al.
Publicado: (2012)

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
por: Jankowska, Ewa A., et al.
Publicado: (2013)

Management strategies in heart failure with preserved ejection fraction
por: Wintrich, Jan, et al.
Publicado: (2022)

Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose—the randomized controlled HOMe aFers study
por: Emrich, I. E., et al.
Publicado: (2020)

Profiling of the Klebsiella pneumoniae Phosphoproteome under Iron-Limited and Iron-Replete Conditions
por: Reitzel, Chelsea, et al.
Publicado: (2023)

Sarcopaenia complicating heart failure
por: da Fonseca, Guilherme Wesley Peixoto, et al.
Publicado: (2019)

Sleep‐disordered breathing in heart failure: facts and numbers
por: Pietrock, Charlotte, et al.
Publicado: (2017)

Muscle wasting and sarcopenia in heart failure: a brief overview of the current literature
por: von Haehling, Stephan
Publicado: (2018)

Bone in heart failure
por: Loncar, Goran, et al.
Publicado: (2020)

The Transcriptional Landscape of Campylobacter jejuni under Iron Replete and Iron Limited Growth Conditions
por: Butcher, James, et al.
Publicado: (2013)

Ferric carboxymaltose for the treatment of iron‐deficient heart failure patients: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Safety and Efficacy of Intravenous Iron Sucrose for Iron-Deficiency Anemia in Children and Adolescents With Inflammatory Bowel Disease
por: Sabe, Ramy, et al.
Publicado: (2019)

Effects of developmental iron deficiency and post-weaning iron repletion on the levels of iron transporter proteins in rats
por: Oh, Sugyoung, et al.
Publicado: (2015)

Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
por: McDonagh, Theresa, et al.
Publicado: (2015)

Intravenous Iron Technique Evaluation in Chronic Heart Failure With Iron Deficiency Anemia
por: Gosavi, Rohit, et al.
Publicado: (2023)

Publishing in a heart failure journal—where lies the scientific interest?
por: Emami, Amir, et al.
Publicado: (2017)

ESC Heart Failure increases its impact factor
por: Anker, Markus S., et al.
Publicado: (2020)

Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry
por: von Haehling, Stephan, et al.
Publicado: (2017)

A practical approach to the guideline‐directed pharmacological treatment of heart failure with reduced ejection fraction
por: Abdin, Amr, et al.
Publicado: (2022)

Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials
por: Hamed, Mohamed, et al.
Publicado: (2023)

Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial)
por: Abdin, Amr, et al.
Publicado: (2023)

Improving the Outcome of Patients With Heart Failure: Assessment of Iron Deficiency and Intravenous Iron Replacement
por: Yera, Hassan O, et al.
Publicado: (2023)

The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study
por: Jankowska, Ewa A, et al.
Publicado: (2011)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

A year in heart failure: updates of clinical and preclinical findings
por: Bäck, Magnus, et al.
Publicado: (2023)

Early-Life Iron Deficiency and Subsequent Repletion Alters Development of the Colonic Microbiota in the Pig
por: Knight, Laura C., et al.
Publicado: (2019)

Prenatal Iron Deficiency and Replete Iron Status Are Associated with Adverse Birth Outcomes, but Associations Differ in Ghana and Malawi
por: Oaks, Brietta M, et al.
Publicado: (2019)

Intravenous iron therapy for patients with heart failure: expanding body of evidence
por: Adlbrecht, Christopher
Publicado: (2019)

Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
por: Sato, Ryosuke, et al.
Publicado: (2022)

Creating an impact, not an impression: ESC Heart Failure in its seventh year
por: von Haehling, Stephan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nrn54hnvrjrlq6qrkasgk692jm